Arcturus Therapeutics Holdings Inc.
ARCT
$14.74
-$0.89-5.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -55.04% | -15.35% | 18.73% | -6.49% | 16.39% |
| Total Depreciation and Amortization | -17.06% | -16.25% | -14.64% | -10.68% | -4.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -26.20% | -27.73% | -28.01% | -27.93% | -16.99% |
| Change in Net Operating Assets | 86.22% | 86.43% | -88.38% | 42.96% | -3.69% |
| Cash from Operations | -11.99% | 34.43% | -24.31% | 2.94% | 5.52% |
| Capital Expenditure | 57.14% | 82.94% | 64.51% | 79.12% | 91.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 81.11% | 89.17% | 64.51% | 79.12% | 91.05% |
| Total Debt Issued | -100.00% | -100.00% | -- | -- | -25.00% |
| Total Debt Repaid | 100.00% | -- | -- | 25.00% | 25.00% |
| Issuance of Common Stock | 897.61% | 285.49% | 146.99% | -72.42% | -83.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 897.61% | -109.75% | 146.99% | 113.67% | -83.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.30% | 15.42% | -11.17% | 24.23% | -0.75% |